Dr. Estela Rodriguez· @Latinamd · X·· 13 小时前评分70
正文 · 原文
💃🍷 Eating tapas while watching the TOP #lungcancer abstracts roll in from #ESMO26 in Madrid!
🔬 From today’s DeLLphi-305 results with tarlatamab in SCLC to upcoming data on KRAS G12C, EGFR/MET combinations & next-gen ADCs in NSCLC — so much to look forward to!
What are YOU most excited about? 👇
#LungCancer #LCSM #ESMO26 🇪🇸 @myESMO
33 浏览 · 0 赞 · 1 转发 · 0 回复
会议摘要
LBA3按 Presidential Symposium I 对上
Tarlatamab plus durvalumab (durva) vs durva as 1L maintenance (1LM) therapy following durva, platinum, and etoposide (1L durva + EP) in extensive-stage small cell lung cancer (ES-SCLC): Primary analysis of the phase 3 DeLLphi-305 trial
https://esmocongress.esmo.org来源：Dr. Estela Rodriguez · x.com